… This review also focuses on drug resistance by ABC efflux transporters in cancer cells,
particularly hepatocellular carcinoma (HCC) and colorectal carcinoma (CRC) cells. Some aspects …

… Of the six anticancer agents prescribed for treatment of colorectal carcinomas, we observed
… patients with colorectal carcinoma. Expression of MRP2 increased in cisplatin-resistant cell …

… and progress of colorectal carcinoma and MDR. The combined detection of PIK3CA
andPIK3CB is important for patients with colorectal carcinoma in prognosis and optimal therapy. …

… In this study, xenograft models of nude mice with human colorectal carcinoma were
established to determine whether TAM had the same effect in vivo as in vitro on MDR and its …

… the relationship between multidrug resistance protein (MRP) … liver carcinomas originating
from colorectal carcinomas, we … colorectal tumors and 44 metastatic liver tumors of colorectal …

… in patients with colorectal carcinomas ssion of the MDR] … In conclusion, multidrug resistance
in colorectal carcinomas is … .1, 1989; Weinstein et the MDR] gene. Future studies will have to …

… involved in conferring the chemoresistant phenotype to human colorectal carcinomas (HCCs),
we determined the mdr 1 mRNA expression level (mdr 1 EL) in surgical specimens from …

… of Beclin1, Raptor, Rictor, and multidrug resistance gene MDR-1 in CRC and analyzed their
… relationship between expression levels and chemotherapy resistance and CRC prognosis. …

… The difference of miR-222 expression in multidrug-resistant CRC cells To determine if
miRNAs are involved in the development of MDR in human colorectal carcinoma cells, we …

… Colorectal carcinoma is a frequent cause of cancer… MDR (multidrug resistance) in colorectal
carcinoma cells. We analysed miRNA expression levels between MDR colorectal carcinoma …